Patent · US5288852A · A · US
Human tumor necrosis factor polypeptides
- (11) Publication number
- US5288852A
- (21) Application number
- US-8444593-A
- (22) Filing date
- 1993-07-01
- (30) Priority date
- 1984-03-06
- (43) Publication date
- 1994-02-22
- (45) Date of grant
- 1994-02-22
- (52) CPC
- C07K Peptides: 14/525, 2319/00, 2319/034, 2319/75
- A61K Preparations for medical, dental or toiletry purposes: 38/00
- C12N Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media: 15/70
- Y10S Technical subjects covered by former uspc cross-reference art collections [xracs] and digests: 930/144
- (73) Assignee
- DAINIPPON PHARMACEUTICAL CO
- (54) Title
- Human tumor necrosis factor polypeptides
- (57) Abstract
A novel cloned DNA encoding a human tumor necrosis factor (TNF), a vector having said DNA inserted thereinto, a host transformed with said vector and a novel human TNF polypeptide, and processes for producing them.
- Full text
- View on Google Patents
Claims (4)
- A polypeptide having human tumor necrosis factor activity and being selected from the group consisting of (a) the polypeptide having the amino acid sequence of the following formula, and (b) a polypeptide having an amino acid sequence resulting from the addition of one or two amino acid residues from the precursor portion of said polypeptide (a) to the N-terminus of the following formula: ##STR131##
- A human tumor necrosis factor polypeptide claimed in claim 1 having the following amino acid sequence: ##STR132##
- A human tumor necrosis factor precursor polypeptide having the following amino acid sequence: ##STR133## or the said polypeptide having a methionine residue at the N-terminus.
- A pharmaceutical composition which comprises an anti-tumor effective amount of a polypeptide as defined in claim 1 as an active ingredient and a vehicle or a stabilizer therefor.
Citations (14)
- EP0131789A2
- EP0158286A2
- EP0166996A1
- EP0168214A2
- EP0183198A1
- JPS6030688A
- US4495282A
- US4677063A
- US4677064A
- US4677197A
- US4879226A
- WO8602381A1
- WO8603751A2
- WO8604606A1
Record as JSON
{
"publication_number": "US5288852A",
"country": "US",
"kind": "A",
"title": "Human tumor necrosis factor polypeptides",
"abstract": "A novel cloned DNA encoding a human tumor necrosis factor (TNF), a vector having said DNA inserted thereinto, a host transformed with said vector and a novel human TNF polypeptide, and processes for producing them.",
"claims": [
"1. A polypeptide having human tumor necrosis factor activity and being selected from the group consisting of (a) the polypeptide having the amino acid sequence of the following formula, and (b) a polypeptide having an amino acid sequence resulting from the addition of one or two amino acid residues from the precursor portion of said polypeptide (a) to the N-terminus of the following formula: ##STR131##",
"2. A human tumor necrosis factor polypeptide claimed in claim 1 having the following amino acid sequence: ##STR132##",
"3. A human tumor necrosis factor precursor polypeptide having the following amino acid sequence: ##STR133## or the said polypeptide having a methionine residue at the N-terminus.",
"4. A pharmaceutical composition which comprises an anti-tumor effective amount of a polypeptide as defined in claim 1 as an active ingredient and a vehicle or a stabilizer therefor."
],
"cpc": [
"C07K 14/525",
"A61K 38/00",
"C07K 2319/00",
"C07K 2319/034",
"C07K 2319/75",
"C12N 15/70",
"Y10S 930/144"
],
"assignees": [
"DAINIPPON PHARMACEUTICAL CO"
],
"filing_date": "1993-07-01",
"publication_date": "1994-02-22",
"grant_date": "1994-02-22",
"priority_date": "1984-03-06",
"application_number": "US-8444593-A",
"family_id": "27550127",
"citations": [
"EP0131789A2",
"EP0158286A2",
"EP0166996A1",
"EP0168214A2",
"EP0183198A1",
"JPS6030688A",
"US4495282A",
"US4677063A",
"US4677064A",
"US4677197A",
"US4879226A",
"WO8602381A1",
"WO8603751A2",
"WO8604606A1"
]
}
Record 4,120 of 5,000 in Patents full text (MLC-0201). Request the full dataset.